Efficacy and Tolerability of a New Extended-Release Formulation of Nicotinic Acid in Korean Adults With Mixed Dyslipidemia: An 8-Week, Multicenter, Prospective, Randomized, Double-Blind, and Placebo-Controlled Trial
Latest Information Update: 24 Oct 2011
At a glance
- Drugs Niacin (Primary)
- Indications Dyslipidaemias
- Focus Registrational; Therapeutic Use
- 24 Oct 2011 New trial record